205 related articles for article (PubMed ID: 25714023)
21. Photoactivation of Akt1/GSK3β Isoform-Specific Signaling Axis Promotes Pancreatic β-Cell Regeneration.
Huang L; Jiang X; Gong L; Xing D
J Cell Biochem; 2015 Aug; 116(8):1741-54. PubMed ID: 25736682
[TBL] [Abstract][Full Text] [Related]
22. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation.
Lu Y; Nie D; Witt WT; Chen Q; Shen M; Xie H; Lai L; Dai Y; Zhang J
Mol Cancer Ther; 2008 Oct; 7(10):3203-11. PubMed ID: 18852124
[TBL] [Abstract][Full Text] [Related]
23. Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
Fu YM; Lin H; Liu X; Fang W; Meadows GG
J Cell Physiol; 2010 Aug; 224(2):491-500. PubMed ID: 20432447
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-α induces increased lung vascular permeability: a role for GSK3α/β.
Barton-Pai A; Feleder C; Johnson A
Eur J Pharmacol; 2011 Apr; 657(1-3):159-66. PubMed ID: 21316358
[TBL] [Abstract][Full Text] [Related]
25. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype.
McAlpine CS; Huang A; Emdin A; Banko NS; Beriault DR; Shi Y; Werstuck GH
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1113-22. PubMed ID: 25767272
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice.
Nørregaard R; Tao S; Nilsson L; Woodgett JR; Kakade V; Yu AS; Howard C; Rao R
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F650-60. PubMed ID: 25608967
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the functions of brain GSK3α: Possible synergy with GSK3β upregulation and reversal by antidepressant treatment in a mouse model of depressive-like behaviour.
Pavlov D; Markova N; Bettendorff L; Chekhonin V; Pomytkin I; Lioudyno V; Svistunov A; Ponomarev E; Lesch KP; Strekalova T
Behav Brain Res; 2017 Sep; 335():122-127. PubMed ID: 28803855
[TBL] [Abstract][Full Text] [Related]
29. Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro.
Sato S; Takahashi S; Asamoto M; Naiki T; Naiki-Ito A; Asai K; Shirai T
Prostate; 2010 Feb; 70(3):229-38. PubMed ID: 19790239
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of oxidored-nitro domain containing protein 1 induces growth inhibition and apoptosis in human prostate cancer PC3 cells.
Shan Z; Hou Q; Zhang N; Guo L; Zhang X; Ma Y; Zhou Y
Oncol Rep; 2014 Nov; 32(5):1939-46. PubMed ID: 25118646
[TBL] [Abstract][Full Text] [Related]
32. GSK3α, not GSK3β, drives hippocampal NMDAR-dependent LTD via tau-mediated spine anchoring.
Draffin JE; Sánchez-Castillo C; Fernández-Rodrigo A; Sánchez-Sáez X; Ávila J; Wagner FF; Esteban JA
EMBO J; 2021 Jan; 40(2):e105513. PubMed ID: 33197065
[TBL] [Abstract][Full Text] [Related]
33. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
Darrington RS; Campa VM; Walker MM; Bengoa-Vergniory N; Gorrono-Etxebarria I; Uysal-Onganer P; Kawano Y; Waxman J; Kypta RM
Int J Cancer; 2012 Sep; 131(6):E872-83. PubMed ID: 22539113
[TBL] [Abstract][Full Text] [Related]
34. Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain.
Soutar MP; Kim WY; Williamson R; Peggie M; Hastie CJ; McLauchlan H; Snider WD; Gordon-Weeks PR; Sutherland C
J Neurochem; 2010 Nov; 115(4):974-83. PubMed ID: 20831597
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway.
Zhu H; Han B; Pan X; Qi H; Xu L
J Clin Pharm Ther; 2012 Feb; 37(1):65-70. PubMed ID: 21410737
[TBL] [Abstract][Full Text] [Related]
36. miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells.
He K; Tong D; Zhang S; Cai D; Wang L; Yang Y; Gao L; Chang S; Guo B; Song T; Li A; Huang C
Int J Oncol; 2015 Oct; 47(4):1528-36. PubMed ID: 26315788
[TBL] [Abstract][Full Text] [Related]
37. Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.
Mishra R; Nagini S; Rana A
Mol Cancer; 2015 Feb; 14():20. PubMed ID: 25645517
[TBL] [Abstract][Full Text] [Related]
38. Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors.
Amaral B; Capacci A; Anderson T; Tezer C; Bajrami B; Lulla M; Lucas B; Chodaparambil JV; Marcotte D; Kumar PR; Murugan P; Spilker K; Cullivan M; Wang T; Peterson AC; Enyedy I; Ma B; Chen T; Yousaf Z; Calhoun M; Golonzhka O; Dillon GM; Koirala S
ACS Chem Neurosci; 2023 Mar; 14(6):1080-1094. PubMed ID: 36812145
[TBL] [Abstract][Full Text] [Related]
39. Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.
Wu X; Stenson M; Abeykoon J; Nowakowski K; Zhang L; Lawson J; Wellik L; Li Y; Krull J; Wenzl K; Novak AJ; Ansell SM; Bishop GA; Billadeau DD; Peng KW; Giles F; Schmitt DM; Witzig TE
Blood; 2019 Jul; 134(4):363-373. PubMed ID: 31101621
[TBL] [Abstract][Full Text] [Related]
40. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
